Reply:

References

1. 1.↵
   1. Barnes SR,
   2. Ng TS,
   3. Montagne A, et al

   . Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI. Magn Reson Med 2016;75:1967–77 doi:10.1002/mrm.25793 pmid:26077645

   CrossRefPubMed
2. 2.↵
   1. Sourbron SP,
   2. Buckley DL

   . On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med 2011;66:735–45 doi:10.1002/mrm.22861 pmid:21384424

   CrossRefPubMed
3. 3.↵
   1. Bergamino M,
   2. Saitta L,
   3. Barletta L, et al

   . Measurement of blood-brain barrier permeability with T1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms. ISRN Neurosci 2013;2013:905279 doi:10.1155/2013/905279 pmid:24959569

   CrossRefPubMed
4. 4.↵
   1. Thrippleton MJ,
   2. Backes WH,
   3. Sourbron S, et al

   . Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations. Alzheimers Dement 2019;15:840–58 doi:10.1016/j.jalz.2019.01.013 pmid:31031101

   CrossRefPubMed
5. 5.↵
   1. Weidman EK,
   2. Foley CP,
   3. Kallas O, et al

   . Evaluating permeability surface-area product as a measure of blood-brain barrier permeability in a murine model. AJNR Am J Neuroradiol 2016;37:1267–74 doi:10.3174/ajnr.A4712 pmid:26965465

   Abstract/FREE Full Text
6. 6.↵
   1. Montagne A,
   2. Barnes SR,
   3. Sweeney MD, et al

   . Blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015;85:296–302 doi:10.1016/j.neuron.2014.12.032 pmid:25611508

   CrossRefPubMed